Monte Rosa Therapeutics, Inc. (GLUE)
17.23
+0.24
(+1.41%)
USD |
NASDAQ |
Dec 10, 16:00
17.22
-0.02
(-0.09%)
After-Hours: 20:00
Monte Rosa Therapeutics EPS Diluted (Quarterly): -0.3287 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 2.020 |
| AVITA Medical, Inc. | -0.4644 |
| NanoVibronix, Inc. | -0.9086 |
| Mirum Pharmaceuticals, Inc. | 0.051 |
| Day One Biopharmaceuticals, Inc. | -0.1908 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.08M |
| Revenue (Quarterly) | 12.77M |
| Total Expenses (Quarterly) | 39.85M |
| Enterprise Value | 770.89M |
| Gross Profit Margin (Quarterly) | 83.59% |
| Profit Margin (Quarterly) | -212.1% |
| Earnings Yield | 1.77% |
| Operating Earnings Yield | 0.64% |
| Normalized Earnings Yield | 1.772 |